U.S. markets closed

Bio-Rad Laboratories, Inc. (BIO)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
583.89-12.49 (-2.09%)
At close: 4:02PM EDT

580.75 -3.14 (-0.54%)
After hours: 5:28PM EDT

Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Breakdown
ttm
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Total Revenue
2,700,778
2,545,626
2,311,659
2,289,415
2,160,153
Cost of Revenue
1,179,697
1,107,804
1,054,663
1,066,264
972,754
Gross Profit
1,521,081
1,437,822
1,256,996
1,223,151
1,187,399
Operating Expense
1,083,635
1,026,865
1,027,335
1,033,979
1,059,243
Operating Income
437,446
410,957
229,661
189,172
128,156
Net Non Operating Interest Income Expense
1,631
-3,661
7,084
2,638
-2,814
Other Income Expense
4,867,077
4,500,354
2,024,342
320,856
-27,534
Pretax Income
5,306,142
4,907,638
2,261,081
512,659
97,805
Tax Provision
1,208,373
1,101,371
502,406
147,045
-24,444
Net Income Common Stockholders
4,097,769
3,806,267
1,758,675
365,614
122,249
Diluted NI Available to Com Stockholders
4,097,769
3,806,267
1,758,675
365,614
122,249
Basic EPS
-
127.86
58.93
12.10
3.87
Diluted EPS
-
126.20
58.27
11.94
3.82
Basic Average Shares
-
29,768
29,843
29,836
29,655
Diluted Average Shares
-
30,160
30,184
30,228
30,034
Total Operating Income as Reported
437,446
410,957
229,661
-103,341
116,650
Total Expenses
2,263,332
2,134,669
2,081,998
2,100,243
2,031,997
Net Income from Continuing & Discontinued Operation
4,097,769
3,806,267
1,758,675
365,614
122,249
Normalized Income
348,601
312,595
183,659
137,806
138,769
Interest Income
-
18,200
30,500
26,600
19,100
Interest Expense
16,569
21,861
23,416
23,962
21,914
Net Interest Income
1,631
-3,661
7,084
2,638
-2,814
EBIT
5,322,711
4,929,499
2,284,497
536,621
119,719
EBITDA
5,459,911
-
-
-
-
Reconciled Cost of Revenue
1,179,697
1,107,804
1,054,663
1,066,264
972,754
Reconciled Depreciation
137,200
138,100
134,200
138,100
148,700
Net Income from Continuing Operation Net Minority Interest
4,097,769
3,806,267
1,758,675
365,614
122,249
Total Unusual Items Excluding Goodwill
4,854,743
4,502,154
2,024,442
320,856
-27,534
Total Unusual Items
4,854,743
4,502,154
2,024,442
320,856
-27,534
Normalized EBITDA
605,168
565,445
394,255
353,865
295,953
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
1,105,575
1,008,482
449,426
93,048
-11,014